City
Epaper

Woman with rare autoimmune disorder successfully treated during pregnancy

By IANS | Updated: July 25, 2024 18:35 IST

New Delhi, July 24 Bengaluru doctors successfully treated a 32-year-old woman with a rare autoimmune disease amid her ...

Open in App

New Delhi, July 24 Bengaluru doctors successfully treated a 32-year-old woman with a rare autoimmune disease amid her pregnancy.

Autoimmune disorders like Factor 13 acquired deficiency can complicate pregnancies, as antibodies generated by the mother may affect foetal development, particularly the heart.

Factor 13 deficiency is exceedingly rare, occurring in approximately 1 in 2-3 million individuals, and requires specialised care.

The patient, Shradha (name changed), faced multiple fertility challenges due to the autoimmune disorders, including ANA (antinuclear antibody), APL (antiphospholipid antibody), and NK cell deficiency.

Despite undergoing multiple treatments like IUI and IVF, she experienced three consecutive miscarriages.

It was during her second miscarriage, that Shradha was diagnosed with the rare condition, which necessitated the use of blood thinners throughout pregnancy.

Shradha's pregnancy journey was fraught with complications, including frequent bleeding episodes. She conceived naturally on her fourth attempt but continued to face challenges, including spontaneous bleeding.

"The rare condition of inhibitors to Factor 13 leads to deficiency. This is not inherited but can develop due to pre-existing autoimmune conditions. Managing pregnancy with Factor 13 deficiency is exceptionally rare, especially when complicated by acquired inhibitors," said Dr. Poornima M Gowda, Consultant Obstetrician and Gynecologist at Cloudnine Hospital, Benagaluru.

The treatment involved regular blood transfusions to maintain stable Factor 13 levels. Despite the challenges, Shradha delivered a baby girl prematurely at 34 weeks.

The baby, now over six months old, is doing well, said Dr. Poornima.

The chances of the baby developing the same problem are minimal, as the condition is not genetic but will be monitored, she added.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalSouth Korea: Water storage rate at drought-hit Gangneung's reservoir rises for 1st time in 52 days

International"Reflection of deep civilizational links...": MEA shares pictures from Mauritius PM's visit to Ram Janmabhoomi Temple

EntertainmentAP Dhillon shares the unusual course of his new track ‘Without Me’

EntertainmentAjay Devgn wishes his ‘strongest critic, softest corner’ Yug on 15th birthday

BusinessIndieVisual Crosses 1,000 Videos for 150 Clients: Redefining Video Production Infrastructure for India's Enterprises

Technology Realted Stories

TechnologyLogistic and industrial leasing in India poised to cross 60 MSF by year-end: Report

TechnologyAdani Power signs pact to supply 2,400 MW power to Bihar

TechnologyKey takeaways from SEBI's move to ease IPO, mutual fund, FPI regulations

TechnologyPfizer, Moderna shares slump as US govt plan to link Covid vaccines to child deaths: Report

TechnologyPOCO expands M7 Plus 5G line-up with new 4GB limited edition variant this festive season